Daan Gene Co. Hits Day Low of CNY 5.68 Amid Price Pressure

Daan Gene Co., Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable decline today, with its stock price dropping by 5.02%. The stock reached an intraday low of CNY 5.68, reflecting ongoing challenges faced by the company. Over the past week, Daan Gene has seen a decrease of 8.83%, and its performance over the last month shows a decline of 9.84%. Year-to-date, the stock is down 4.7%, significantly underperforming the China Shanghai Composite, which has seen a decline of 3.92% in the same period. The company's financial metrics indicate a concerning trend, with net sales falling to CNY 164.93 million and a net profit of CNY -60.32 million, marking a substantial drop of 355.4%. Daan Gene has reported negative results for ten consecutive quarters, highlighting persistent difficulties in achieving profitability. With a market capitalization of CNY 8,638 million, the company continues to face challenges in maintaining its market position, as evidenced by its long-term performance metrics, which show a staggering 63.89% decline over the past three years.